System suitability in bioanalytical LC/MS/MS

Chad J. Briscoe, Mark R. Stiles, David S. Hage

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

System suitability is widely recognized as a critical component of bioanalysis. This paper discusses a generic system suitability test that monitors instrument performance throughout a run when used for liquid chromatography tandem mass spectrometry (LC/MS/MS) in bioanalysis. This system suitability process is designed to ensure that the LC/MS/MS system is performing in a manner that leads to the production of accurate and reproducible data that can be submitted with confidence to regulatory agencies. This process contains tests for signal stability, carryover, and instrument response. This approach is integrated throughout an analytical run and has been used in the analysis of over 25,000 batches of clinical samples. Two case studies are presented in which quality control samples and standards meet all acceptance criteria (based on Standard Operating Procedures and the Food and Drug Administration's recommendations for bioanalytical method validation) but failed the proposed system suitability test, and thus were rejected. In these case studies, the concentrations of a significant number of clinical samples (over 35%) were affected, resulting in changes of more than 15% when the samples were reanalyzed. These data indicate that the poor performance of an LC/MS/MS system could adversely affect the calculated concentrations of unknown samples even though the results for quality control samples appear to be acceptable.

Original languageEnglish (US)
Pages (from-to)484-491
Number of pages8
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume44
Issue number2
DOIs
StatePublished - Jun 28 2007

Fingerprint

Quality Control
Quality control
Liquid chromatography
United States Food and Drug Administration
Tandem Mass Spectrometry
Liquid Chromatography
Mass spectrometry

Keywords

  • Bioanalysis
  • Instrument qualification
  • LC/MS/MS
  • System suitability

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • Clinical Biochemistry

Cite this

System suitability in bioanalytical LC/MS/MS. / Briscoe, Chad J.; Stiles, Mark R.; Hage, David S.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 44, No. 2, 28.06.2007, p. 484-491.

Research output: Contribution to journalArticle

Briscoe, Chad J. ; Stiles, Mark R. ; Hage, David S. / System suitability in bioanalytical LC/MS/MS. In: Journal of Pharmaceutical and Biomedical Analysis. 2007 ; Vol. 44, No. 2. pp. 484-491.
@article{98ec447f8fa44a29ae6bebe0f24f1cf1,
title = "System suitability in bioanalytical LC/MS/MS",
abstract = "System suitability is widely recognized as a critical component of bioanalysis. This paper discusses a generic system suitability test that monitors instrument performance throughout a run when used for liquid chromatography tandem mass spectrometry (LC/MS/MS) in bioanalysis. This system suitability process is designed to ensure that the LC/MS/MS system is performing in a manner that leads to the production of accurate and reproducible data that can be submitted with confidence to regulatory agencies. This process contains tests for signal stability, carryover, and instrument response. This approach is integrated throughout an analytical run and has been used in the analysis of over 25,000 batches of clinical samples. Two case studies are presented in which quality control samples and standards meet all acceptance criteria (based on Standard Operating Procedures and the Food and Drug Administration's recommendations for bioanalytical method validation) but failed the proposed system suitability test, and thus were rejected. In these case studies, the concentrations of a significant number of clinical samples (over 35{\%}) were affected, resulting in changes of more than 15{\%} when the samples were reanalyzed. These data indicate that the poor performance of an LC/MS/MS system could adversely affect the calculated concentrations of unknown samples even though the results for quality control samples appear to be acceptable.",
keywords = "Bioanalysis, Instrument qualification, LC/MS/MS, System suitability",
author = "Briscoe, {Chad J.} and Stiles, {Mark R.} and Hage, {David S.}",
year = "2007",
month = "6",
day = "28",
doi = "10.1016/j.jpba.2007.03.003",
language = "English (US)",
volume = "44",
pages = "484--491",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - System suitability in bioanalytical LC/MS/MS

AU - Briscoe, Chad J.

AU - Stiles, Mark R.

AU - Hage, David S.

PY - 2007/6/28

Y1 - 2007/6/28

N2 - System suitability is widely recognized as a critical component of bioanalysis. This paper discusses a generic system suitability test that monitors instrument performance throughout a run when used for liquid chromatography tandem mass spectrometry (LC/MS/MS) in bioanalysis. This system suitability process is designed to ensure that the LC/MS/MS system is performing in a manner that leads to the production of accurate and reproducible data that can be submitted with confidence to regulatory agencies. This process contains tests for signal stability, carryover, and instrument response. This approach is integrated throughout an analytical run and has been used in the analysis of over 25,000 batches of clinical samples. Two case studies are presented in which quality control samples and standards meet all acceptance criteria (based on Standard Operating Procedures and the Food and Drug Administration's recommendations for bioanalytical method validation) but failed the proposed system suitability test, and thus were rejected. In these case studies, the concentrations of a significant number of clinical samples (over 35%) were affected, resulting in changes of more than 15% when the samples were reanalyzed. These data indicate that the poor performance of an LC/MS/MS system could adversely affect the calculated concentrations of unknown samples even though the results for quality control samples appear to be acceptable.

AB - System suitability is widely recognized as a critical component of bioanalysis. This paper discusses a generic system suitability test that monitors instrument performance throughout a run when used for liquid chromatography tandem mass spectrometry (LC/MS/MS) in bioanalysis. This system suitability process is designed to ensure that the LC/MS/MS system is performing in a manner that leads to the production of accurate and reproducible data that can be submitted with confidence to regulatory agencies. This process contains tests for signal stability, carryover, and instrument response. This approach is integrated throughout an analytical run and has been used in the analysis of over 25,000 batches of clinical samples. Two case studies are presented in which quality control samples and standards meet all acceptance criteria (based on Standard Operating Procedures and the Food and Drug Administration's recommendations for bioanalytical method validation) but failed the proposed system suitability test, and thus were rejected. In these case studies, the concentrations of a significant number of clinical samples (over 35%) were affected, resulting in changes of more than 15% when the samples were reanalyzed. These data indicate that the poor performance of an LC/MS/MS system could adversely affect the calculated concentrations of unknown samples even though the results for quality control samples appear to be acceptable.

KW - Bioanalysis

KW - Instrument qualification

KW - LC/MS/MS

KW - System suitability

UR - http://www.scopus.com/inward/record.url?scp=34249951279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249951279&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2007.03.003

DO - 10.1016/j.jpba.2007.03.003

M3 - Article

C2 - 17433601

AN - SCOPUS:34249951279

VL - 44

SP - 484

EP - 491

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 2

ER -